{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:27:17Z","timestamp":1786116437033,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"A randomized controlled, open, multicenter clinical study to evaluate the outcome of ovarian endometriosis cyst resection versus electrocoagulation on ovarian function","award":["SHDC12019113"],"award-info":[{"award-number":["SHDC12019113"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Uterine corpus endometrial carcinoma (UCEC) ranks as the 6th most common malignancy among women. Emerging evidence indicates that the dysregulation of tRNA-derived fragments (tRFs) is involved in the pathogenesis of multiple cancer types, including UCEC; however, the molecular mechanisms underlying the roles of tRFs in UCEC remain poorly characterized. Desmocollin3 (DSC3), a transmembrane protein, is predominantly expressed in the basal and suprabasal layers of normal stratified epithelia. While accumulating evidence has implicated DSC3 in the pathogenesis of multiple disease entities, its functional role in UCEC remains elusive. The present study is designed to investigate the functional significance and underlying molecular mechanisms of tRF-19-79MP9PJZ in the progression of\u00a0UCEC. In this study, tRF-19-79MP9PJZ was found to be significantly upregulated in UCEC tissues and cell lines, with its elevated expression correlating with unfavorable prognostic outcomes in UCEC patients. Furthermore, tRF-19-79MP9PJZ knockdown was observed to suppress the proliferative and migratory capacities of UCEC cells, while concurrently enhancing apoptotic processes. At the mechanistic level, tRF-19-79MP9PJZ was demonstrated to facilitate UCEC progression through targeted regulation of\u00a0DSC3. Collectively, this study elucidates a previously uncharacterized mechanism whereby tRF-19-79MP9PJZ drives UCEC development, thereby highlighting the potential of the tRF-19-79MP9PJZ\/DSC3 axis as a therapeutic target for UCEC intervention.<\/jats:p>","DOI":"10.1007\/s13577-026-01432-x","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:54:55Z","timestamp":1786010095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel tRNA-derived fragment, tRF-19-79MP9PJZ, promotes uterine corpus endometrial carcinoma progression by targeting DSC3"],"prefix":"10.1007","volume":"39","author":[{"given":"Huabo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"10333","key":"1432_CR1","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer. Lancet. 2022;399(10333):1412\u201328.","journal-title":"Lancet"},{"key":"1432_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-43139-0_2","volume":"943","author":"D Gupta","year":"2017","unstructured":"Gupta D. Clinical behavior and treatment of endometrial cancer. Adv Exp Med Biol. 2017;943:47\u201374.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"1432_CR3","first-page":"224","volume":"74","author":"N Jokhadze","year":"2024","unstructured":"Jokhadze N, Das A, Dizon DS. Global cancer statistics: a healthy population relies on population health. CA Cancer J Clin. 2024;74(3):224\u20136.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1432_CR4","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1432_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ajog.2020.12.1213","volume":"224","author":"K Matsuo","year":"2021","unstructured":"Matsuo K, Mandelbaum RS, Matsuzaki S, et al. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema. Am J Obstet Gynecol. 2021;224(6):574\u201384.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1432_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","volume":"7","author":"V Makker","year":"2021","unstructured":"Makker V, MacKay H, Ray-Coquard I, et al. Endometrial cancer. Nat Rev Dis Primers. 2021;7(1):88.","journal-title":"Nat Rev Dis Primers"},{"key":"1432_CR7","volume":"71","author":"Y Zhan","year":"2023","unstructured":"Zhan Y, Liu Y, Yang R, et al. CircPTEN suppresses human clear cell renal carcinoma progression and resistance to mTOR inhibitors by targeting epigenetic modification. Drug Resist Updat (Reviews and commentaries in antimicrobial and anticancer chemotherapy). 2023;71:101003.","journal-title":"Drug Resist Updat (Reviews and commentaries in antimicrobial and anticancer chemotherapy)"},{"issue":"1","key":"1432_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01531-x","volume":"21","author":"X Chong","year":"2022","unstructured":"Chong X, Chen J, Zheng N, et al. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN. Mol Cancer. 2022;21(1):118.","journal-title":"Mol Cancer"},{"key":"1432_CR9","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zheng N, Li J, et al. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist Updat (Reviews and commentaries in antimicrobial and anticancer chemotherapy). 2022;65:100886.","journal-title":"Drug Resist Updat (Reviews and commentaries in antimicrobial and anticancer chemotherapy)"},{"issue":"1","key":"1432_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00446-x","volume":"19","author":"S Cheng","year":"2024","unstructured":"Cheng S, Li C, Liu L, et al. Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p\/LRIG1 axis in bladder carcinoma. Biol Direct. 2024;19(1):20.","journal-title":"Biol Direct"},{"issue":"6","key":"1432_CR11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.cell.2016.05.046","volume":"165","author":"H Goodarzi","year":"2016","unstructured":"Goodarzi H, Nguyen HCB, Zhang S, et al. Modulated expression of specific tRNAs drives gene expression and cancer progression. Cell. 2016;165(6):1416\u201327.","journal-title":"Cell"},{"issue":"1","key":"1432_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-022-01270-y","volume":"15","author":"W Yang","year":"2022","unstructured":"Yang W, Gao K, Qian Y, et al. A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1\/MED29 and ELK4\/MED29 axes. J Hematol Oncol. 2022;15(1):53.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1432_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13046-018-0745-z","volume":"37","author":"SQ Huang","year":"2018","unstructured":"Huang SQ, Sun B, Xiong ZP, et al. The dysregulation of tRNAs and tRNA derivatives in cancer. J Exp Clin Cancer Res (CR). 2018;37(1):101.","journal-title":"J Exp Clin Cancer Res (CR)"},{"key":"1432_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-981-32-9620-6_6","volume":"1187","author":"NH Kwon","year":"2021","unstructured":"Kwon NH, Lee JY, Kim S. Role of tRNAs in breast cancer regulation. Adv Exp Med Biol. 2021;1187:121\u201345.","journal-title":"Adv Exp Med Biol"},{"issue":"43","key":"1432_CR15","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1038\/s41388-023-02825-0","volume":"42","author":"R Garc\u00eda-V\u00edlchez","year":"2023","unstructured":"Garc\u00eda-V\u00edlchez R, A\u00f1azco-Guenkova AM, L\u00f3pez J, et al. N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer. Oncogene. 2023;42(43):3169\u201381.","journal-title":"Oncogene"},{"issue":"24","key":"1432_CR16","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2217\/epi-2022-0349","volume":"14","author":"T Qian","year":"2022","unstructured":"Qian T, Yu X, Xu A, et al. tRF-20-S998LO9D inhibits endometrial carcinoma by upregulating SESN2. Epigenomics. 2022;14(24):1563\u201377.","journal-title":"Epigenomics"},{"issue":"1","key":"1432_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12079-022-00690-2","volume":"17","author":"Y Pekarsky","year":"2023","unstructured":"Pekarsky Y, Balatti V, Croce CM. tRNA-derived fragments (tRFs) in cancer. J Cell Commun Signal. 2023;17(1):47\u201354.","journal-title":"J Cell Commun Signal"},{"issue":"2","key":"1432_CR18","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1080\/21655979.2021.2023796","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu Z, Zhao W, et al. tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A). Bioengineered. 2022;13(2):2087\u201398.","journal-title":"Bioengineered"},{"issue":"8","key":"1432_CR19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/15476286.2020.1776506","volume":"17","author":"D Yao","year":"2020","unstructured":"Yao D, Sun X, Zhou L, et al. OncotRF: an online resource for exploration of tRNA-derived fragments in human cancers. RNA Biol. 2020;17(8):1081\u201391.","journal-title":"RNA Biol"},{"issue":"7683","key":"1432_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature25005","volume":"552","author":"HK Kim","year":"2017","unstructured":"Kim HK, Fuchs G, Wang S, et al. A transfer-RNA-derived small RNA regulates ribosome biogenesis. Nature. 2017;552(7683):57\u201362.","journal-title":"Nature"},{"issue":"1","key":"1432_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41392-020-00217-4","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, Yao L, Yu X, et al. Action mechanisms and research methods of tRNA-derived small RNAs. Signal Transduct Target Ther. 2020;5(1):109.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"1432_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1261\/rna.066126.118","volume":"24","author":"C Kuscu","year":"2018","unstructured":"Kuscu C, Kumar P, Kiran M, et al. TRNA fragments (tRFs) guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner. RNA. 2018;24(8):1093\u2013105.","journal-title":"RNA"},{"issue":"D1","key":"1432_CR23","doi-asserted-by":"publisher","first-page":"D421","DOI":"10.1093\/nar\/gkab1023","volume":"50","author":"JH Wang","year":"2022","unstructured":"Wang JH, Chen WX, Mei SQ, et al. TsRFun: a comprehensive platform for decoding human tsRNA expression, functions and prognostic value by high-throughput small RNA-Seq and CLIP-Seq data. Nucleic Acids Res. 2022;50(D1):D421\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1432_CR24","doi-asserted-by":"publisher","first-page":"R669","DOI":"10.1186\/bcr1273","volume":"7","author":"MM Oshiro","year":"2005","unstructured":"Oshiro MM, Kim CJ, Wozniak RJ, et al. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res (BCR). 2005;7(5):R669-680.","journal-title":"Breast Cancer Res (BCR)"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01432-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01432-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01432-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:54:56Z","timestamp":1786010096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01432-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01432-x","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Shanghai First Maternity and Infant Hospital (approved number: [IRB: H-1126\u2013074]), and written informed consent was obtained from all participants. The animal experiments were conducted in accordance with the ARRIVE guidelines and approved by the Animal Ethical and Welfare Committee of Shanghai First Maternity and Infant Hospital (approval number: [FM-IH-20240727]).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients in this study provided their consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"122"}}